Physician profile

Justin Lo

Emergency Medicine · Phoenix, AZ

NPI 1740667526

$1,399.92

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$47.56

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $718.57 2021-2024
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $172.34 2021
Redhill Biopharma INC. $121.87 2021
Csl Behring $114.62 2022
Nestle Healthcare Nutrition INC. $109.22 2021
Lilly USA, LLC $80.38 2019
Allergan, INC. $29.85 2020
Janssen Pharmaceuticals, INC $29.59 2022
Abbott Laboratories $23.48 2023 Proclaim

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Justin Lo

$1,399.92

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/5700436/justin-lo

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.